ERBB2 and cancer: According to studies, human epidermal growth factor receptor 2 (HER2) is overexpressed in breast, gastric, ductal, pancreatic, NSCLC, and GB tumors and has been linked to carcinogenesis, suggesting that it might be exploited as a prognostic marker and a therapeutic target in cancer treatment (60).